Accent Microcell (NSE:ACCENTMIC) Debt-to-EBITDA : (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ACCENTMIC Accent Microcell Ltd NSE:ACCENTMIC
49 GF Score
Price ₹681.75
! 6 Warning Signs
View Full Analysis

What is Accent Microcell Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Accent Microcell's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was ₹5 Mil. Accent Microcell's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was ₹3 Mil. Accent Microcell's annualized EBITDA for the quarter that ended in Mar. 2026 was ₹739 Mil. Accent Microcell's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 was 0.01.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Accent Microcell's Debt-to-EBITDA or its related term are showing as below:

NSE:ACCENTMIC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01   Med: 0.69   Max: 2.46
Current: 0.01

During the past 6 years, the highest Debt-to-EBITDA Ratio of Accent Microcell was 2.46. The lowest was 0.01. And the median was 0.69.

NSE:ACCENTMIC's Debt-to-EBITDA is ranked better than
99.85% of 677 companies
in the Drug Manufacturers industry
Industry Median: 1.64 vs NSE:ACCENTMIC: 0.01

Accent Microcell  (NSE:ACCENTMIC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Accent Microcell Debt-to-EBITDA Related Terms

Accent Microcell Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Accent Microcell's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accent Microcell Debt-to-EBITDA Chart

Accent Microcell Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-EBITDA
Get a 7-Day Free Trial - - - - -

Accent Microcell Semi-Annual Data
Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Debt-to-EBITDA Get a 7-Day Free Trial - - - - -

NSE:ACCENTMIC vs ZTS: Debt-to-EBITDA Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accent Microcell Debt-to-EBITDA vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Accent Microcell's Debt-to-EBITDA falls into.


NSE:ACCENTMIC
49GF Score
Accent Microcell Ltd NSE:ACCENTMIC
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accent Microcell Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Accent Microcell's Debt-to-EBITDA for the fiscal year that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.348 + 3.437) / 634.583
=0.01

Accent Microcell's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.348 + 3.437) / 739.064
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Mar. 2026) EBITDA data.

Accent Microcell Business Description

Address Shyamal Cross Roads, Anandnagar Road, 314, Shangrilla Arcade, Satellite, Ahmedabad, GJ, IND, 380015
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
49GF Score

Get the complete analysis for NSE:ACCENTMIC

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹681.75
Price